Literature DB >> 1428124

Inhibition of prekallikrein activation in human plasma by components of bovine plasma.

K M Weerasinghe1, E P Kirby.   

Abstract

Contact of plasma with a negatively charged surface activates prekallikrein and factor XII reciprocally. Activation of prekallikrein by several activators was impaired in bovine plasma when compared to that in human plasma. The activated partial thromboplastin time of bovine plasma, induced by several activators, was significantly longer than that of human plasma. Cleavage of [125I]factor XII was optimum at 10 min in human plasma but took up to 60 min in bovine plasma. Addition of bovine plasma to human plasma caused significant inhibition of dextran sulfate-induced prekallikrein activation, indicating that the impaired rate of contact activation in bovine plasma is due to the presence of inhibitors. The inhibitory effect was greater at lower concentrations of dextran sulfate but could not be abolished by increasing the concentration. The inhibitory activity eluted in two peaks at low and medium salt concentrations on carboxymethyl ion-exchange chromatography of bovine plasma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1428124     DOI: 10.1007/bf00918975

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  29 in total

1.  The interrelationship of coagulation of plasma and release of peptides.

Authors:  J MARGOLIS
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

2.  Isolation and characterization of an inhibitor of factor XIIa from bovine plasma.

Authors:  R D Thornton; E P Kirby
Journal:  J Biol Chem       Date:  1987-09-15       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Human factor XII (Hageman factor).

Authors:  K Fujikawa; E W Davie
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Properties of sulfatides in factor-XII-dependent contact activation.

Authors:  G Tans; J H Griffin
Journal:  Blood       Date:  1982-01       Impact factor: 22.113

6.  Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.

Authors:  H Saito; M C Poon; W Vicic; G H Goldsmith; J E Menitove
Journal:  J Lab Clin Med       Date:  1978-07

Review 7.  Molecular assembly in the contact phase of the Hageman factor system.

Authors:  C G Cochrane; J H Griffin
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

8.  Inhibition of Hageman factor activation.

Authors:  H L Nossel; H Rubin; M Drillings; R Hsieh
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

9.  The binding of bovine factor XII to kaolin.

Authors:  E P Kirby; P J McDevitt
Journal:  Blood       Date:  1983-04       Impact factor: 22.113

10.  Interaction of bovine factor XIIa with an inhibitor from bovine plasma.

Authors:  R D Thornton; E P Kirby
Journal:  Biochim Biophys Acta       Date:  1988-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.